You are here

  • Home
  • Archive
  • Volume 29, Issue 4
  • Clinical impact and cost-effectiveness of primary cytology versus human papillomavirus testing for cervical cancer screening in England

Article metrics

Article menu

Download PDFPDF

Original Article
Clinical impact and cost-effectiveness of primary cytology versus human papillomavirus testing for cervical cancer screening in England

 

Online download statistics by month:

Online download statistics by month: April 2019 to October 2024

AbstractFullPdf
Apr 2019968954
May 2019615594117
Jun 201934833341
Jul 201920118253
Aug 201917515936
Sep 2019948750
Oct 201911410827
Nov 201911610554
Dec 2019645722
Jan 202014612640
Feb 20201009831
Mar 202011110623
Apr 202012310933
May 202013011236
Jun 20201049623
Jul 202011410526
Aug 2020908324
Sep 20201029632
Oct 202018617673
Nov 202017817944
Dec 202015515041
Jan 202121220558
Feb 202116716233
Mar 202123622930
Apr 202113413332
May 202121821462
Jun 202114313950
Jul 2021969330
Aug 2021646122
Sep 2021958931
Oct 2021878140
Nov 202119416875
Dec 2021968930
Jan 202214614339
Feb 202213512544
Mar 202210710240
Apr 2022989326
May 202211811630
Jun 20221029934
Jul 202211810645
Aug 20221039428
Sep 202210710225
Oct 20221039631
Nov 202214813648
Dec 2022726911
Jan 2023998324
Feb 202315814732
Mar 2023727118
Apr 2023958532
May 2023908833
Jun 2023877913
Jul 2023616113
Aug 2023625622
Sep 2023827612
Oct 202313412332
Nov 202318416743
Dec 202314511455
Jan 20241369326
Feb 20241329618
Mar 202413612785
Apr 2024907734
May 202413010537
Jun 202412612231
Jul 20241049933
Aug 202410488117
Sep 2024666320
Oct 202428248
Total878281382512